Picture of Mithra Pharmaceuticals SA logo

MITRA — Mithra Pharmaceuticals SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Mithra: Positive Preclinical Data On Estetrol's Efficacy In Wound Healing

Oct 12 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * MITHRA ANNOUNCES POSITIVE PRECLINICAL DATA DEMONSTRATING
ESTETROL'S EFFICACY IN WOUND HEALING
    * ROBUST MECHANISM OF ACTION DATA SHOW THAT ESTETROL
IMPROVES
WOUND CLOSURE AND DAMPENS LOCAL INFLAMMATION, SUPPORTED BY A
UNIQUE GENE SIGNATURE, COMPARED TO OTHER ESTROGENS
    * DEVELOPMENT OF A NOVEL ESTETROL FORMULATION FOR TOPICAL
APPLICATION IS ONGOING, WITH POTENTIAL BENEFIT IN BOTH ACUTE AND
CHRONIC WOUND SETTINGS
    * CLINICAL PROGRAM IS EXPECTED TO BE LAUNCHED IN H2 OF 2023
WITH
PUNCH BIOPSY STUDY AIMED TO EXPLORE SAFETY AND EFFICACY OF
MITHRA’S E4 TOPICAL LEAD FORMULATION

Further company coverage:  MITRA.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mithra Pharmaceuticals SA

See all news